DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
You have strategic business objectives. We have the network and expertise to help you realize your goals. We assemble a team that works closely with you to develop a customized investment solution.
Together, we can design a tailored investment approach to support corporate or family office initiatives, market expansion objectives, business development strategies, or any other focused business goals you have in mind.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.